.jpg "Thomas Eschenhagen, MD photo")
University Medical Center Hamburg Eppendorf, Germany
Stem Cell Reports Author
Dr. Eschenhagen studied Medicine and specialized in Pharmacology at the University of Hamburg, where he completed a postgraduate study of Molecular Biology in 1992. Since 2002, he is Director of the Department of Experimental Pharmacology and Toxicology at the University of Hamburg. From 2011 to 2020, he served as Chairman of the German Centre for Cardiovascular Research, which transformed the translational landscape in Germany. He is member of the German Academy of Science Leopoldina (2008) and was President of ISHR (2019-2022). His research focusses on molecular and regenerative therapies of heart failure. Eschenhagen pioneered the generation of 3D engineered heart tissue for preclinical drug development and cardiac repair. His research is funded through various public and private grants, including an ERC AG.
INSIGHTS INTO DISEASE MECHANISMS FROM STEM CELL RESEARCH
Thursday, June 12, 2025
2:00 PM – 3:30 PM HK Time
ENGINEERED HEART TISSUE FOR DISEASE MODELING AND EFFICACY TESTING
Thursday, June 12, 2025
3:05 PM – 3:25 PM HK Time